08
Nov
2007
MicroPhage (Longmont) aims to become a worldwide leader in rapid bacterial diagnostics, both identification and antibiotic susceptibility & resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The lead Dx products expected in late 2008 are for the identification of methicillin-resitant Staphylococcus aureus (MRSA). Follow-on Dx products for additional bacterial pathogens may include: Vancomycin-resistant [...]
08
Nov
2007
You may recall a little over a year ago Endo Pharmaceuticals (NASDAQ: ENDP) acquired RxKinetix whose lead product was RK-0202, a topical oral-rinse with the active ingredient formulated in its proprietary ProGelz® drug delivery platform and was in Phase II. It sounds as if great progress is being made on RK-0202 which subsequently has become [...]
06
Nov
2007
How Much Ya Got?
Posted in My Rants
I often hear the commonly quoted metric of 10 years and $1B as the time and cost to bring a drug to market. After seeing, hearing, observing drugs reaching the market for less than $1B I decided to do some poking around in an effort to validate said metric. Well valid it is according to [...]
05
Nov
2007
Had To Tell Someone!
Posted in My Rants
Since architecting CLSDF some 2 and-a-half years ago and enjoying the ups and downs of the ride since launching one rule of thumb I’ve been adhering to is to keep my personal life out of the blog, for who cares what movie I saw over the weekend or where I took my dog hiking. Relevant [...]
01
Nov
2007
The Envelope Please…
Posted in CO Private: Nanodisc, CO Private: ValveXchange, CO Private: Ventrus Bio
The finalists for this years BioWest Venture Showcase have been named. The Venture Showcase will be held on Friday 7 December at Denver’s Grand Hyatt. The winner will receive the $10,000 Faegre & Benson Venture Showcase award at the CBSA’s Annual Awards Luncheon on the same day. I am working on embedding a poll for [...]
Life Science Deal Flow PARTNERS
-
